LATEST
NEET-UG previous year question

In gene therapy of Adenosine Deaminase (ADA) deficiency, the patient requires periodic infusion of genetically engineered lymphocytes because:

Asked in NEET (UG) 2022 · 160 Qs · Zoology

Tap an option to check your answer.

Show answer and explanation

Correct answer: (D) Genetically engineered lymphocytes are not immortal cells.

In ADA gene therapy, lymphocytes are taken from the patient, grown in culture, given a working ADA gene with a retroviral vector, and returned to the body.

These lymphocytes have a limited lifespan; they are not immortal. As they die, ADA activity is lost, so the patient needs periodic infusions. A permanent cure would need the gene put into bone-marrow stem cells or at the embryonic stage. The answer is option (D).

All solved Zoology questions →